About Discovery Genomics
Discovery Genomics is a company based in Minneapolis (United States) founded in 2000 was acquired by Immusoft in March 2016.. Discovery Genomics has raised $4 million across 3 funding rounds from investors including Immusoft, Bio-Techne and HHS. Discovery Genomics offers products and services including Quote Comparison Service. Discovery Genomics operates in a competitive market with competitors including Insitro, BridgeBio, GSK, ATAI and Forge Biologics, among others.
- Headquarter Minneapolis, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Discovery Genomics
Discovery Genomics offers a comprehensive portfolio of products and services, including Quote Comparison Service. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Online tool for comparing Medicare plans and getting quotes
Funding Insights of Discovery Genomics
Discovery Genomics has successfully raised a total of $4M across 3 strategic funding rounds. The most recent funding activity was a Grant round of $1.77 million completed in February 2011. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Grant — $1.8M
-
First Round
First Round
(02 Aug 2001)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2011 | Amount | Grant - Discovery Genomics | Valuation |
investors |
|
| Mar, 2010 | Amount | Grant - Discovery Genomics | Valuation |
investors |
|
| Aug, 2001 | Amount | Series A - Discovery Genomics | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Discovery Genomics
Discovery Genomics has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include Immusoft, Bio-Techne and HHS. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Developer of biotech reagents, instruments and clinical diagnostic products
|
Founded Year | Domain | Location | |
|
Public health and human services are overseen by HHS.
|
Founded Year | Domain | Location | |
|
B cells are programmed as biofactories for therapeutic protein delivery.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Discovery Genomics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Discovery Genomics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Discovery Genomics Comparisons
Competitors of Discovery Genomics
Discovery Genomics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Insitro, BridgeBio, GSK, ATAI and Forge Biologics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
An AI-enabled platform is developed for infectious disease treatment.
|
|
| domain | founded_year | HQ Location |
Therapeutics for genetic diseases are developed through targeted interventions.
|
|
| domain | founded_year | HQ Location |
Developer of pharmaceuticals and vaccines for various therapeutic areas
|
|
| domain | founded_year | HQ Location |
A biopharmaceutical company accelerating innovative mental health treatments.
|
|
| domain | founded_year | HQ Location |
Gene therapies for rare diseases are developed to treat patients.
|
|
| domain | founded_year | HQ Location |
Gene therapies for rare diseases including retinal dystrophies are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Discovery Genomics
When was Discovery Genomics founded?
Discovery Genomics was founded in 2000 and raised its 1st funding round 1 year after it was founded.
Where is Discovery Genomics located?
Discovery Genomics is headquartered in Minneapolis, United States. It is registered at Minneapolis, Minnesota, United States.
Is Discovery Genomics a funded company?
Discovery Genomics is a funded company, having raised a total of $4M across 3 funding rounds to date. The company's 1st funding round was a Series A of $4M, raised on Aug 02, 2001.
What does Discovery Genomics do?
Discovery Genomics, a functional genomics company created to discover gene functions, conduct drug target validations, and design therapeutic agents based on genomics information. The company holds exclusive licenses from the University of Minnesota to develop technologies related to knock-downs in Zebrafish using a proprietary Morphant(TM) technology and to the use of the Sleeping Beauty Transposon(TM). Both technologies may be used for functional genomics and the discovery of drug targets. The transposon may have applications in gene therapy. Morphant(TM) knock-downs are used to suppress and thereby study the functions of particular genes.
Who are the top competitors of Discovery Genomics?
Discovery Genomics's top competitors include Spark Therapeutics, BridgeBio and Forge Biologics.
What products or services does Discovery Genomics offer?
Discovery Genomics offers Quote Comparison Service.
Who are Discovery Genomics's investors?
Discovery Genomics has 3 investors. Key investors include Immusoft, Bio-Techne, and HHS.